Macrolide Resistance of Mycoplasma pneumoniae and Its Detection Rate by Real-Time PCR in Primary and Tertiary Care Hospitals
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: This study aimed to evaluate the prevalence of Mycoplasma pneumoniae in primary and tertiary care hospitals and its macrolide resistance rate. Methods: Nasopharyngeal swabs were collected from 195 pediatric patients in primary and tertiary care hospitals from October to November 2010. The AccuPower MP real-time PCR kit (Bioneer, Korea) was used for the detection of M. pneumoniae. Direct amplicon sequencing was performed to detect point mutations conferring resistance to macrolides in the 23S rRNA gene. Results: Among the 195 specimens, 17 (8.7%) were M. pneumoniae positive, and 3 of the strains (17.6%) obtained from these 17 specimens displayed the A2063G mutation in 23S rRNA. Three macrolide-resistant M. pneumoniae isolates were isolated from patients hospitalized at the primary care hospital. The positive rates of M. pneumoniae for the primary and tertiary care hospitals were 12.1% (15/124) and 2.8% (2/71), respectively (P=0.033). Conclusions: The positive rate of M. pneumoniae in the primary care hospital was higher than that in the tertiary care hospital. Simultaneous detection of M. pneumoniae and macrolide-resistant mutation genes in the 23S rRNA by real-time PCR is needed for rapid diagnosis and therapy of M. pneumoniae infections.
Abstract
Background: This study aimed to evaluate the prevalence of Mycoplasma pneumoniae in primary and tertiary care hospitals and its macrolide resistance rate. Methods: Nasopharyngeal swabs were collected from 195 pediatric patients in primary and tertiary care hospitals from October to November 2010. The AccuPower MP real-time PCR kit (Bioneer, Korea) was used for the detection of M. pneumoniae. Direct amplicon sequencing was performed to detect point mutations conferring resistance to macrolides in the 23S rRNA gene. Results: Among the 195 specimens, 17 (8.7%) were M. pneumoniae positive, and 3 of the strains (17.6%) obtained from these 17 specimens displayed the A2063G mutation in 23S rRNA. Three macrolide-resistant M. pneumoniae isolates were isolated from patients hospitalized at the primary care hospital. The positive rates of M. pneumoniae for the primary and tertiary care hospitals were 12.1% (15/124) and 2.8% (2/71), respectively (P=0.033). Conclusions: The positive rate of M. pneumoniae in the primary care hospital was higher than that in the tertiary care hospital. Simultaneous detection of M. pneumoniae and macrolide-resistant mutation genes in the 23S rRNA by real-time PCR is needed for rapid diagnosis and therapy of M. pneumoniae infections.
참고문헌 (17)
- Waites KB, "Mycoplasma pneumoniae and its role as a human pathogen", Clin Microbiol Rev, 17, pp.697~728 (2004)
- Winchell JM, "Detection of Mycoplasma pneumoniae by real-time PCR", Methods Mol Biol, 943, pp.149~158 (2013)
- Okada T, "Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children", Clin Infect Dis, 55, pp.1642~1649 (2012)
- Diaz MH, "Detection of Mycoplasma pneumoniae and Chlamydophila pneumoniae directly from respiratory clinical specimens using a rapid real-time polymerase chain reaction assay", Diagn Microbiol Infect Dis, 73, pp.278~280 (2012)
- Yao JDC, "Antibacterial agents, In Manual of clinical microbiology. 10th ed", pp.1043~1081 (2011), ASM press
- Yoo SJ, "Differences in the frequency of 23S rRNA gene mutations in Mycoplasma pneumoniae between children and adults with community-acquired pneumonia: clinical impact of mutations conferring macrolide resistance", Antimicrob Agents Chemother, 56, pp.6393~6396 (2012)
- Liu Y, "Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in Shanghai, China", Diagn Microbiol Infect Dis, 67, pp.355~358 (2010)
- Ferwerda A, "Respiratory tract infections by Mycoplasma pneumoniae in children: a review of diagnostic and therapeutic measures", Eur J Pediatr, 160, pp.483~491 (2001)
- 조민철, "Comparison of Sputum and Nasopharyngeal Swab Specimens for Molecular Diagnosis of Mycoplasma pneumoniae, Chlamydophila pneumoniae, and Legionella pneumophila", Annals of Laboratory Medicine, 32(2), pp.133~138 (2012), 대한진단검사의학회
- Zhao F, "Evaluation of a new real-time PCR assay for detection of Mycoplasma pneumoniae in clinical specimens", Biomed Environ Sci, 25, pp.77~81 (2012)
- Lim HK, "Significance of polymerase chain reaction test for diagnosis of Mycoplasma pneumoniae pneumonia", J Korean Pediatr Soc, 42, pp.173~179 (1999)
- Sasaki A, "The effect of inhaled corticosteroids on Chlamydophila pneumoniae and Mycoplasma pneumoniae infection in children with bronchial asthma", J Infect Chemother, 15, pp.99~103 (2009)
- 이미애, "호흡기 검체에서 폐렴의 세균성 원인균 검출을 위한 다중 PCR 검사의 임상적 평가", Annals of Clinical Microbiology, 13(1), pp.40~46 (2010), 대한임상미생물학회
- Hong KB, "Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000–2011", Emerg Infect Dis, 19, pp.1281~1284 (2013)
- Cao B, "High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China", Clin Infect Dis, 51, pp.189~194 (2010)
- Isozumi R, "Adult community-acquired pneumonia caused by macrolide resistant Mycoplasma pneumoniae", Respirology, 14, pp.1206~1208 (2009)
- 오지은, "Mycoplasma pneumoniae의 macrolide 내성과 연관된 유전자 변이의 검출", Korean Journal of Pediatrics, 53(2), pp.178~183 (2010), 대한소아과학회